Compensatory Mutations in Rifampicin-Resistant Tuberculosis: A Threat to Global Control

Strategic Insights -

Tuberculosis (TB) is a significant global health issue, with the emergence of rifampicin-resistant TB (RR-TB) posing a substantial challenge to control efforts. Research from Zhejiang, China, has shed light on the characteristics of compensatory mutations in RR-TB strains and their association with transmission dynamics in coastal regions of Eastern China. A recent study, published in BMC Microbiology, aimed to characterize the spectrum of compensatory mutations in RR-TB isolates and assess their impact on transmission in a well-developed coastal region.

Key Takeaways:

  • The study analyzed 180 RR-TB isolates from Ningbo, China, collected between 2021 and 2024, and found that 28.9% harbored putative compensatory mutations, predominantly in the rpoC gene.
  • Isolates with compensatory mutations were significantly more likely to be part of genomic transmission clusters than those without such mutations, with an odds ratio of 4.28 (95% CI: 2.07-8.85).
  • The study found no significant differences in demographic or clinical characteristics between clustered and non-clustered cases, indicating that compensatory mutations play a key role in sustaining the RR-TB epidemic in the region.
  • Phylogenetic analysis revealed ongoing local transmission of compensated RR-TB strains, underscoring the need for enhanced molecular surveillance and targeted interventions to curb the spread of compensated RR-TB.

Statistics:

  • 28.9% of the 180 RR-TB isolates analyzed harbored putative compensatory mutations.
  • The odds ratio of isolates with compensatory mutations being part of genomic transmission clusters was 4.28 (95% CI: 2.07-8.85).
  • No significant differences were observed in demographic or clinical characteristics between clustered and non-clustered cases.

Sources:

  • Xiangchen Li et al. (2025). Characteristics of compensatory mutations in rifampicin-resistant tuberculosis and their association with compensated transmission in Ningbo, China. BMC Microbiology, 2025;25(1):634.
  • NewsRx. Studies from Xiangchen Li and Co-Researchers Yield New Data on Tuberculosis (Characteristics of compensatory mutations in rifampicin-resistant tuberculosis and their association with compensated transmission in Ningbo, China). TB & Outbreaks Week. October 21, 2025; p 519.